Schrodinger, Inc. SEC filings SDGR
Schrodinger, Inc. has 539 filings in SEC EDGAR's recent list, going back to May 5, 2010. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| S-8 | Employee stock plan registration | May 7, 2025 | — |
| S-8 | Employee stock plan registration | Jul 31, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 28, 2024 | — |
| 424B5 | Prospectus supplement | May 24, 2023 | — |
| S-8 | Employee stock plan registration | Nov 3, 2022 | — |
| S-8 | Employee stock plan registration | Aug 4, 2022 | — |
| S-8 | Employee stock plan registration | Jun 17, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| S-3ASR | Automatic shelf registration | Mar 4, 2021 | — |
| S-8 | Employee stock plan registration | Mar 4, 2021 | — |
| 424B4 | Prospectus | Aug 13, 2020 | — |
| S-1MEF | Filing | Aug 12, 2020 | — |
| S-1 | Registration statement | Aug 10, 2020 | — |
| S-8 | Employee stock plan registration | Feb 6, 2020 | — |
| 424B4 | Prospectus | Feb 6, 2020 | — |
| S-1MEF | Filing | Feb 5, 2020 | — |
| S-1/A | Amended registration statement | Jan 27, 2020 | — |
| S-1 | Registration statement | Jan 10, 2020 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SDGR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1490978
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.